Items without sitelinks
From determinar.ia.br - Determine suas informações
Showing below up to 50 results in range #5,751 to #5,800.
- Harmful effects of substances, Drugs, medicaments or biological substances, Drugs primarily affecting the autonomic nervous system, Other parasympathomimetics (Q107064)
- Harmful effects of mineral salts, not elsewhere classified (Q107063)
- Harmful effects of substances, Drugs, medicaments or biological substances, Drugs primarily affecting the autonomic nervous system, Other parasympatholytics or spasmolytics (Q107062)
- Harmful effects of substances, Drugs, medicaments or biological substances, Drugs primarily affecting the autonomic nervous system, Anticholinesterase agents (Q107061)
- Harmful effects of Bisphosphonates (Q107060)
- Harmful effects of other diuretics (Q107059)
- Harmful effects of drugs affecting uric acid metabolism (Q107058)
- Harmful effects of agents primarily affecting water-balance and mineral or uric acid metabolism, Vitamin D and derivatives (Q107057)
- Harmful effects of Carbonic-anhydrase inhibitors (Q107056)
- Harmful effects of electrolytic, caloric or water-balance agents (Q107055)
- Harmful effects of Benzothiadiazine derivatives (Q107054)
- Harmful effects of Loop diuretics (Q107053)
- Harmful effects of Mineralocorticoids antagonists (Q107052)
- Harmful effects of etodolac (Q107051)
- Harmful effects of cloral derivatives (Q107050)
- Harmful effects of Mineralocorticoids (Q107049)
- Harmful effects of promazine (Q107048)
- Harmful effects of mixed sedatives or hypnotics, not elsewhere classified (Q107047)
- Harmful effects of paraldehyde (Q107046)
- Harmful effects of bromine compounds (Q107045)
- Harmful effects of anaesthetics or therapeutic gases, intravenous anaesthetics (Q107044)
- Pelger-Huet anomaly (Q107043)
- Harmful effects of barbiturates (Q107042)
- Harmful effects of benzodiazepines (Q107041)
- May-Hegglin anomaly (Q107040)
- Harmful effects of anaesthetics or therapeutic gases, other inhaled anaesthetics (Q107039)
- Harmful effects of anaesthetics or therapeutic gases, local anaesthetics (Q107038)
- Harmful effects of anaesthetics or therapeutic gases, nitrous oxide (Q107037)
- Harmful effects of anaesthetics or therapeutic gases, gamma hydroxybutyrate (Q107036)
- Harmful effects of anaesthetics or therapeutic gases, ketamine (Q107035)
- Persistent polyclonal lymphocytosis (Q107034)
- Harmful effects of anaesthetics or therapeutic gases, other specified general anaesthetic (Q107033)
- Harmful effects of anaesthetics or therapeutic gases, unspecified general anaesthetics (Q107032)
- Chronic hepatitis C, co-infected with human immunodeficiency virus, with cirrhosis, without complications of cirrhosis (Q107031)
- Alder-Reilly anomaly (Q107030)
- Cholecystenteric fistula, not elsewhere classified (Q107029)
- Chronic hepatitis C, co-infected with human immunodeficiency virus, with cirrhosis, with complications of cirrhosis (Q107028)
- Cholecystocolonic fistula (Q107027)
- Papulonecrotic tuberculid (Q107026)
- Chorea due to Lesch-Nyhan Syndrome (Q107025)
- Chorea due to organic acidaemias (Q107024)
- Lichen scrofulosorum (Q107023)
- Diplogonoporus grandis infection (Q107022)
- Infection by larvae of multiceps (Q107021)
- Bertielliasis (Q107020)
- Raillietiniasis (Q107019)
- Coenurosis (Q107018)
- Intraabdominal vitelline cyst or remnants (Q107017)
- Umbilical cord vein anomalies, group III (Q107016)
- Umbilical cord vein anomalies, group IV (Q107015)
